Eric J Mao Sara Lewin Jonathan P Terdiman Kendall Beck
10.1136/bmjgast-2018-000243
BMJ Open Gastroenterol
2018 Nov 9;5(1):e000243.
adverse drug reactions antibody targeted therapy inflammatory bowel disease
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30538822/
Case Reports
PMC6254738
30538822
Safety of dual biological therapy in Crohn's disease: a case series of vedolizumab in combination with other biologics
2018